Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

3.13

Margin Of Safety %

28

Put/Call OI Ratio

0.15

EPS Next Q Diff

0.01

EPS Last/This Y

1.96

EPS This/Next Y

0.2

Price

45.29

Target Price

52.51

Analyst Recom

2.2

Performance Q

-4.45

Relative Volume

0.68

Beta

0.67

Ticker: QGEN




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-08-15QGEN49.350.190.016783
2025-08-18QGEN48.650.150.004320
2025-08-19QGEN49.220.15999.994349
2025-08-20QGEN49.20.150.014353
2025-08-21QGEN49.130.140.334622
2025-08-22QGEN49.760.141.004631
2025-08-25QGEN48.90.140.764673
2025-08-26QGEN48.850.160.025041
2025-08-27QGEN48.010.161.005047
2025-08-28QGEN46.140.160.045046
2025-08-29QGEN46.770.100.007552
2025-09-02QGEN46.940.100.007517
2025-09-03QGEN46.70.1058.677821
2025-09-04QGEN47.040.151.008173
2025-09-05QGEN47.550.151.008173
2025-09-08QGEN47.580.151.008173
2025-09-09QGEN47.040.154.008172
2025-09-10QGEN46.010.16999.998237
2025-09-11QGEN46.070.163.678238
2025-09-12QGEN45.280.1530.508238
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-08-15QGEN49.350.098.62.35
2025-08-18QGEN48.630.085.22.35
2025-08-19QGEN49.190.0100.52.35
2025-08-20QGEN49.210.094.22.35
2025-08-21QGEN49.130.093.12.35
2025-08-22QGEN49.750.0101.42.35
2025-08-25QGEN48.900.083.92.35
2025-08-26QGEN48.860.093.42.35
2025-08-27QGEN48.000.083.52.35
2025-08-28QGEN46.140.071.12.35
2025-08-29QGEN46.530.098.92.35
2025-09-02QGEN46.920.099.22.35
2025-09-03QGEN46.740.0163.62.35
2025-09-04QGEN47.030.0170.72.35
2025-09-05QGEN47.550.0173.22.36
2025-09-08QGEN47.580.0166.52.36
2025-09-09QGEN47.040.0158.72.36
2025-09-10QGEN45.990.0151.32.36
2025-09-11QGEN46.060.0166.82.36
2025-09-12QGEN45.290.0155.12.36
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-08-15QGEN0.00-0.193.07
2025-08-18QGEN0.002.773.07
2025-08-19QGEN0.002.773.07
2025-08-20QGEN0.002.773.07
2025-08-21QGEN0.002.773.07
2025-08-22QGEN0.002.773.07
2025-08-25QGEN0.001.043.07
2025-08-26QGEN0.001.043.07
2025-08-27QGEN0.001.042.85
2025-08-28QGEN0.001.042.85
2025-08-29QGEN0.001.042.85
2025-09-02QGEN0.000.592.85
2025-09-03QGEN0.000.592.85
2025-09-04QGEN0.000.592.85
2025-09-05QGEN0.000.592.85
2025-09-08QGEN0.000.372.85
2025-09-09QGEN0.000.372.85
2025-09-10QGEN0.000.372.85
2025-09-11QGEN0.000.373.13
2025-09-12QGEN0.000.373.13
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.6

Avg. EPS Est. Current Quarter

0.59

Avg. EPS Est. Next Quarter

0.61

Insider Transactions

Institutional Transactions

0.37

Beta

0.67

Average Sales Estimate Current Quarter

525

Average Sales Estimate Next Quarter

540

Fair Value

57.78

Quality Score

90

Growth Score

85

Sentiment Score

53

Actual DrawDown %

27.6

Max Drawdown 5-Year %

-37.4

Target Price

52.51

P/E

26.5

Forward P/E

17.88

PEG

3.67

P/S

4.81

P/B

2.8

P/Free Cash Flow

19.67

EPS

1.71

Average EPS Est. Cur. Y​

2.36

EPS Next Y. (Est.)

2.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.3

Relative Volume

0.68

Return on Equity vs Sector %

-14.2

Return on Equity vs Industry %

-0.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

155.1
Qiagen N.V.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 5700
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
stock quote shares QGEN – Qiagen N.V. Stock Price stock today
news today QGEN – Qiagen N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QGEN – Qiagen N.V. yahoo finance google finance
stock history QGEN – Qiagen N.V. invest stock market
stock prices QGEN premarket after hours
ticker QGEN fair value insiders trading